Conference of Deputy Ministers of Health authorized Canadian Blood Services to issue a request for proposals (RFP) for Health Canada-approved A1-PI products
On December 23, 2022, Alpha-1 Canada was informed that the Conference of Deputy Ministers of Health authorized Canadian Blood Services to move forward with issuing a request for proposals (RFP) for Health Canada-approved A1-PI products. An announcement will be shared...
Wave Life Sciences and GSK Announce Collaboration to Drive Discovery and Development of Oligonucleotide Therapeutics Focusing on Novel Genetic Targets
Wave Life Sciences recently hosted Alpha Dan Coffin and his wife Kathi at their offices to speak with employees about living with Alpha-1. Shortly thereafter, Wave announced a collaboration with GSK that will provide GSK with the exclusive global license to Wave’s...
Inhibrx Shares Jump Premarket After Talks With FDA on INBRX-101
“The Alpha-1 Foundation is pleased with the FDA’s indication of a potential for accelerated approval of INHBRX -101. A1F values our strong working relationship with FDA leadership on behalf of our patient community and we are grateful to all of our partners focused on...